Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Falls River Group is a global investment banking firm that provides merger and acquisition (M&A) advisory services to middle-market companies. While the firm is not a biotechnology or pharmaceutical developer, it maintains a dedicated Healthcare & Life Sciences practice that advises on transactions within the medical device, healthcare services, and life science sectors. The firm specializes in sell-side and buy-side advisory, recapitalizations, and strategic corporate divestitures. As the Florida-based partner of IMAP (International M&A Partners), Falls River Group facilitates cross-border transactions through a global network of advisors. Their expertise helps healthcare companies navigate complex market dynamics to achieve strategic growth or exit objectives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Falls River Group.